By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biomedical Advanced Research and Development Authority (BARDA) 

330 C Street, SW
Room G640
Washington  D.C.  20201  U.S.A.
Phone: 202-260-1200 Fax: 202-205-4520



Company News
BARDA Increases Contract Option With Cytori (CYTX) To Advance Countermeasure Clinical Trial 9/19/2016 10:11:41 AM
Moderna Announces Funding Award From BARDA For $8 Million With Potential Of Up To $125 Million To Accelerate Development Of Zika Messenger RNA (mRNA) Vaccine 9/7/2016 11:33:20 AM
BARDA Awards Protein Sciences Corporation Multi-Million Dollar Contract For Pandemic Preparedness 9/7/2016 9:24:45 AM
SAb Biotherapeutics Announces Contract With BARDA To Advance First MERS Treatment 8/24/2016 10:52:50 AM
Regeneron (REGN) Announces Agreement With BARDA For The Manufacturing And Testing Of New Antibodies Against MERS Virus 8/22/2016 6:52:40 AM
Achaogen (AKAO) Awarded $20 Million Contract Option By BARDA To Support Development Of Plazomicin For Multi-Drug Resistant Gram-Negative Infections 6/2/2016 10:35:16 AM
NewLink Genetics (NLNK) Awarded $21.6 Million Contract Option By BARDA For Ebola Vaccine Development 4/25/2016 8:21:16 AM
Spero Hires Former BARDA Anti-Infectives Program Chief 1/19/2016 7:41:11 AM
Vaxart, Inc. Awarded $13.98 Million HHS-BARDA Contract To Support Advanced Development Of Influenza Tablet Vaccine 10/28/2015 11:17:57 AM
SNBL Wins BARDA Contract For Chem And RadNuc Animal Model Development 10/27/2015 10:58:17 AM